Nocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 6, 2011, Pages 1345-1353

  Yuen, Darren A ^b   Kuliszewski, Michael A ^a   Liao, Christine ^a   Rudenko, Dmitriy ^a   Leong Poi, Howard ^b   Chan, Christopher T ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; SODIUM CHLORIDE;

ADULT; AGE DISTRIBUTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY LIGATION; ARTICLE; CELL FUNCTION; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; HEMODIALYSIS; HUMAN; ILIAC ARTERY; MALE; NOCTURNAL HEMODIALYSIS; NONHUMAN; RAT; SEX DIFFERENCE;

ADULT; ANALYSIS OF VARIANCE; ANGIOPOIETIN-1; ANIMALS; BLOOD FLOW VELOCITY; CAPILLARIES; CASE-CONTROL STUDIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HEMODIALYSIS, HOME; HINDLIMB; HUMANS; ISCHEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; ONTARIO; PHENOTYPE; RATS; RATS, NUDE; REGIONAL BLOOD FLOW; STEM CELL TRANSPLANTATION; STEM CELLS; TIME FACTORS;

EID: 79958238555     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10911210     Document Type: Article

References (45)

1. U.S. Renal Data System: 2009 Annual Data Report: Atlas ofChronic Kidney Disease and End-Stage Renal Disease in theUnited States, Bethesda, MD, National Institutes of Health,National Institute of Diabetes and Digestive and Kidney Disease,2009.
2. Zannad F, Kessler M, Lehert P, Grunfeld JP, Thuilliez C, Leizorovicz A, Lechat P: Prevention of cardiovascular events inend-stage renal disease: Results of a randomized trial of fosi-nopril and implications for future studies. Kidney Int 70:1318-1324, 2006.
3. Li Z, Lacson E Jr, Lowrie EG, Ofsthun NJ, Kuhlmann MK, Lazarus JM, Levin NW: The epidemiology of systolic bloodpressure and death risk in hemodialysis patients. Am J KidneyDis 48: 606-615, 2006.
4. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Gronhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Suleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wuthrich RP, Gottlow M, Johnsson E, Zannad F: Rosuvastatinand cardiovascular events in patients undergoing hemodialysis.N Engl J Med 360: 1395-1407, 2009.
5. Stam F, van Guldener C, Schalkwijk CG, Ter wee PM, Donker AJ, Stehouwer CD: Impaired renal function is associatedwith markers of endothelial dysfunction and increasedinflammatory activity. Nephrol Dial Transplant 18: 892-898,2003.
6. Amann K, Breitbach M, Ritz E, Mall G: Myocyte/capillarymismatch in the heart of uremic patients. J Am Soc Nephrol9: 1018-1022, 1998.
7. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation ofputative progenitor endothelial cells for angiogenesis. Science275: 964-967, 1997.
8. Sieveking DP, Buckle A, Celermajer DS, Ng MK: Strikinglydifferent angiogenic properties of endothelial progenitor cellsubpopulations: Insights from a novel human angiogenesisassay. J Am Coll Cardiol 51: 660-668, 2008.
9. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, Dimmeler S: Soluble factors released by endothelialprogenitor cells promote migration of endothelial cellsand cardiac resident progenitor cells. J Mol Cell Cardiol 39:733-742, 2005.
10. Yuen DA, Connelly KA, Advani A, Liao C, Kuliszewski MA, Trogadis J, Thai K, Advani SL, Zhang Y, Kelly DJ, Leong-Poi H, Keating A, Marsden PA, Stewart DJ, Gilbert RE: Culturemodifiedbone marrow cells attenuate cardiac and renal injuryin a chronic kidney disease rat model via a novel antifibroticmechanism. PLoS ONE 5: e9543, 2010.
11. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM: Transcoronarytransplantation of progenitor cells after myocardial infarction.N Engl J Med 355: 1222-1232, 2006.
12. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, Kim DK: Decreased number and impairedangiogenic function of endothelial progenitor cells in patientswith chronic renal failure. Arterioscler Thromb Vasc Biol 24:1246-1252, 2004.
13. Chan CT, Harvey PJ, Picton P, Pierratos A, Miller JA, Floras JS: Short-term blood pressure, noradrenergic, and vasculareffects of nocturnal home hemodialysis. Hypertension 42:925-931, 2003.
14. Yuen D, Pierratos A, Richardson RM, Chan CT: The naturalhistory of coronary calcification progression in a cohort ofnocturnal haemodialysis patients. Nephrol Dial Transplant21: 1407-1412, 2006.
15. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ: Effect offrequent nocturnal hemodialysis vs conventional hemodialysison left ventricular mass and quality of life: A randomizedcontrolled trial. JAMA 298: 1291-1299, 2007.
16. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A:Regression of left ventricular hypertrophy after conversion tonocturnal hemodialysis. Kidney Int 61: 2235-2239, 2002.
17. Chan CT, Mardirossian S, Faratro R, Richardson RM: Improvementin lower-extremity peripheral arterial disease bynocturnal hemodialysis. Am J Kidney Dis 41: 225-229, 2003.
18. Chan CT, Li SH, Verma S: Nocturnal hemodialysis is associatedwith restoration of impaired endothelial progenitor cellbiology in end-stage renal disease. Am J Physiol RenalPhysiol 289: F679-F684, 2005.
19. Daugirdas JT, Greene T, Depner TA, Gotch FA, Star RA: Relationshipbetween apparent (single-pool) and true (doublepool)urea distribution volume. Kidney Int 56: 1928-1933,1999.
20. Jindal KK, Manuel A, Goldstein MB: Percent reduction inblood urea concentration during hemodialysis (PRU). A simpleand accurate method to estimate Kt/V urea. ASAIO Trans33: 286-288, 1987.
21. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S: Erythropoietin is a potent physiologic stimulus for endothelialprogenitor cell mobilization. Blood 102: 1340-1346,2003.
22. Ormiston ML, Deng Y, Stewart DJ, Courtman DW: Innateimmunity in the therapeutic actions of endothelial progenitorcells in pulmonary hypertension. Am J Respir Cell Mol Biol43: 546-554, 2010.
23. Leong-Poi H, Kuliszewski MA, Lekas M, Sibbald M, Teichert-Kuliszewska K, Klibanov AL, Stewart DJ, Lindner JR: Therapeuticarteriogenesis by ultrasound-mediated VEGF165 plasmidgene delivery to chronically ischemic skeletal muscle.Circ Res 101: 295-303, 2007.
24. Takeshita S, Isshiki T, Ochiai M, Eto K, Mori H, Tanaka E, Umetani K, Sato T: Endothelium-dependent relaxation of collateralmicrovessels after intramuscular gene transfer of vascularendothelial growth factor in a rat model of hindlimbischemia. Circulation 98: 1261-1263, 1998.
25. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM: Statin therapy accelerates reendothelialization: A noveleffect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105:3017-3024, 2002.
26. O'Hare AM, Feinglass J, Sidawy AN, Bacchetti P, Rodriguez RA, Daley J, Khuri S, Henderson WG, Johansen KL: Impact ofrenal insufficiency on short-term morbidity and mortality afterlower extremity revascularization: Data from the Departmentof Veterans Affairs' National Surgical Quality ImprovementProgram. J Am Soc Nephrol 14: 1287-1295, 2003.
27. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology ofcardiovascular disease in chronic renal disease. Am J KidneyDis 32: S112-S119, 1998.
28. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E: Atorvastatin in patients with type 2 diabetes mellitusundergoing hemodialysis. N Engl J Med 353: 238-248,2005.
29. O'Hare A, Johansen K: Lower-extremity peripheral arterialdisease among patients with end-stage renal disease. J AmSoc Nephrol 12: 2838-2847, 2001.
30. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T: Transplantation of exvivo expanded endothelial progenitor cells for therapeuticneovascularization. Proc Natl Acad Sci U S A 97: 3422-3427, 2000.
31. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S: Neovascularizationof ischemic myocardium by human bone-marrowderivedangioblasts prevents cardiomyocyte apoptosis, reducesremodeling and improves cardiac function. Nat Med 7:430-436, 2001.
32. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, Imaizumi T: Transplanted cord bloodderivedendothelial precursor cells augment postnatal neovascularization.J Clin Invest 105: 1527-1536, 2000.
33. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T: Therapeuticangiogenesis for patients with limb ischaemia by autologoustransplantation of bone-marrow cells: A pilot study and a randomisedcontrolled trial. Lancet 360: 427-435, 2002.
34. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM: Intracoronarybone marrow-derived progenitor cells in acutemyocardial infarction. N Engl J Med 355: 1210-1221, 2006.
35. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S: Number and migratory activity ofcirculating endothelial progenitor cells inversely correlatewith risk factors for coronary artery disease. Circ Res 89: E1-E7, 2001.
36. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitorcells, vascular function, and cardiovascular risk. N EnglJ Med 348: 593-600, 2003.
37. Guerin AP, Pannier B, Metivier F, Marchais SJ, London GM: Assessment and significance of arterial stiffness in patientswith chronic kidney disease. Curr Opin Nephrol Hypertens17: 635-641, 2008.
38. de Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, HallerH, Fliser D: Uremia causes endothelial progenitor cell deficiency.Kidney Int 66: 641-646, 2004.
39. Herbrig K, Pistrosch F, Oelschlaegel U, Wichmann G, Wagner A, Foerster S, Richter S, Gross P, Passauer J: Increasedtotal number but impaired migratory activity and adhesion ofendothelial progenitor cells in patients on long-term hemodialysis.Am J Kidney Dis 44: 840-849, 2004.
40. Hirschi KK, Ingram DA, Yoder MC: Assessing identity, phenotype,and fate of endothelial progenitor cells. ArteriosclerThromb Vasc Biol 28: 1584-1595, 2008.
41. Popa ER, Harmsen MC, Tio RA, van der Strate BW, Brouwer LA, Schipper M, Koerts J, De Jongste MJ, Hazenberg A, Hendriks M, van Luyn MJ: Circulating CD34_ progenitor cellsmodulate host angiogenesis and inflammation in vivo. J MolCell Cardiol 41: 86-96, 2006.
42. Rehman J, Li J, Orschell CM, March KL: Peripheral blood"endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation107: 1164-1169, 2003.
43. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis.Nat Med 6: 389-395, 2000.
44. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM: Tie2 receptor ligands,angiopoietin-1 and angiopoietin-2, modulate VEGF-inducedpostnatal neovascularization. Circ Res 83: 233-240, 1998.
45. Saif J, Schwarz TM, Chau DY, Henstock J, Sami P, Leicht SF, Hermann PC, Alcala S, Mulero F, Shakesheff KM, Heeschen C, Aicher A: Combination of injectable multiplegrowth factor-releasing scaffolds and cell therapy as anadvanced modality to enhance tissue neovascularization.Arterioscler Thromb Vasc Biol 30: 1897-1904, 2010